Takara Bio (TSE:4974) Long-Term Capital Lease Obligation : 円788 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Takara Bio Long-Term Capital Lease Obligation?

Takara Bio's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was 円788 Mil.

Takara Bio's quarterly Long-Term Capital Lease Obligation stayed the same from Sep. 2023 (円0 Mil) to Dec. 2023 (円0 Mil) but then increased from Dec. 2023 (円0 Mil) to Mar. 2024 (円788 Mil).

Takara Bio's annual Long-Term Capital Lease Obligation declined from Mar. 2022 (円910 Mil) to Mar. 2023 (円821 Mil) and declined from Mar. 2023 (円821 Mil) to Mar. 2024 (円788 Mil).

Takara Bio Long-Term Capital Lease Obligation Historical Data

The historical data trend for Takara Bio's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio Long-Term Capital Lease Obligation Chart

Takara Bio Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

986.00

1,003.00

910.00

821.00

788.00

Takara Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															821.00	-	-	-	788.00

Takara Bio (TSE:4974) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Takara Bio Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Takara Bio's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Takara Bio (TSE:4974) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

TF2:Germany

Address

Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058

Website

http://www.takara-bio.co.jp

Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines